Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor-5-HT1A/5-HT2A/5-HT7 and D2/D3/D4-agents : the synthesis and pharmacological evaluation
Copyright © 2011 Elsevier Ltd. All rights reserved..
Two series of arylpiperazinyl-alkyl quinoline-, isoquinoline-, naphthalene-sulfonamides with flexible (13-26) and semi-rigid (33-36) alkylene spacer were synthesized and evaluated for 5-HT(1A), 5-HT(2A), 5-HT(6), 5-HT(7) and selected compounds for D(2), D(3), D(4) receptors. The compounds with a mixed 5-HT and D receptors profile 16 (N-{4-[4-(3-chlorophenyl)-piperazin-1-yl]-butyl}-3-quinolinesulfonamide) and 36 (4-(4-{2-[4-(4-chloro-phenyl)-piperazin-1-yl]-ethyl}-piperidine-1-sulfonyl)-isoquinoline), displaying antagonistic activity at 5-HT(7), 5-HT(2A), D(2) postsynaptic sites, produced antidepressant-like effects in the forced swim test in mice and showed significant anxiolytic activity in the plus-maze test in rats. The lead compound 36, a multi-receptor 5-HT(2A)/5-HT(7)/D(2)/D(3)/D(4) agent, also displayed significant antipsychotic properties in the MK-801-induced hyperlocomotor activity in mice.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2012 |
---|---|
Erschienen: |
2012 |
Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
---|---|
Enthalten in: |
Bioorganic & medicinal chemistry - 20(2012), 4 vom: 15. Feb., Seite 1545-56 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zajdel, Paweł [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 18.06.2012 Date Revised 09.02.2012 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.bmc.2011.12.039 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM214867692 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM214867692 | ||
003 | DE-627 | ||
005 | 20231224024416.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2012 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.bmc.2011.12.039 |2 doi | |
028 | 5 | 2 | |a pubmed24n0716.xml |
035 | |a (DE-627)NLM214867692 | ||
035 | |a (NLM)22277589 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zajdel, Paweł |e verfasserin |4 aut | |
245 | 1 | 0 | |a Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor-5-HT1A/5-HT2A/5-HT7 and D2/D3/D4-agents |b the synthesis and pharmacological evaluation |
264 | 1 | |c 2012 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 18.06.2012 | ||
500 | |a Date Revised 09.02.2012 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2011 Elsevier Ltd. All rights reserved. | ||
520 | |a Two series of arylpiperazinyl-alkyl quinoline-, isoquinoline-, naphthalene-sulfonamides with flexible (13-26) and semi-rigid (33-36) alkylene spacer were synthesized and evaluated for 5-HT(1A), 5-HT(2A), 5-HT(6), 5-HT(7) and selected compounds for D(2), D(3), D(4) receptors. The compounds with a mixed 5-HT and D receptors profile 16 (N-{4-[4-(3-chlorophenyl)-piperazin-1-yl]-butyl}-3-quinolinesulfonamide) and 36 (4-(4-{2-[4-(4-chloro-phenyl)-piperazin-1-yl]-ethyl}-piperidine-1-sulfonyl)-isoquinoline), displaying antagonistic activity at 5-HT(7), 5-HT(2A), D(2) postsynaptic sites, produced antidepressant-like effects in the forced swim test in mice and showed significant anxiolytic activity in the plus-maze test in rats. The lead compound 36, a multi-receptor 5-HT(2A)/5-HT(7)/D(2)/D(3)/D(4) agent, also displayed significant antipsychotic properties in the MK-801-induced hyperlocomotor activity in mice | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Antipsychotic Agents |2 NLM | |
650 | 7 | |a Isoquinolines |2 NLM | |
650 | 7 | |a Piperazines |2 NLM | |
650 | 7 | |a Quinolines |2 NLM | |
650 | 7 | |a Receptor, Serotonin, 5-HT2A |2 NLM | |
650 | 7 | |a Receptors, Serotonin |2 NLM | |
650 | 7 | |a Sulfonamides |2 NLM | |
650 | 7 | |a serotonin 7 receptor |2 NLM | |
650 | 7 | |a Receptor, Serotonin, 5-HT1A |2 NLM | |
650 | 7 | |a 112692-38-3 |2 NLM | |
700 | 1 | |a Marciniec, Krzysztof |e verfasserin |4 aut | |
700 | 1 | |a Maślankiewicz, Andrzej |e verfasserin |4 aut | |
700 | 1 | |a Satała, Grzegorz |e verfasserin |4 aut | |
700 | 1 | |a Duszyńska, Beata |e verfasserin |4 aut | |
700 | 1 | |a Bojarski, Andrzej J |e verfasserin |4 aut | |
700 | 1 | |a Partyka, Anna |e verfasserin |4 aut | |
700 | 1 | |a Jastrzębska-Więsek, Magdalena |e verfasserin |4 aut | |
700 | 1 | |a Wróbel, Dagmara |e verfasserin |4 aut | |
700 | 1 | |a Wesołowska, Anna |e verfasserin |4 aut | |
700 | 1 | |a Pawłowski, Maciej |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Bioorganic & medicinal chemistry |d 1994 |g 20(2012), 4 vom: 15. Feb., Seite 1545-56 |w (DE-627)NLM074978543 |x 1464-3391 |7 nnns |
773 | 1 | 8 | |g volume:20 |g year:2012 |g number:4 |g day:15 |g month:02 |g pages:1545-56 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.bmc.2011.12.039 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 20 |j 2012 |e 4 |b 15 |c 02 |h 1545-56 |